Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Unique Ziosoft AI Platform Exceeds 2,500 Installations in More Than 30 Countries Globally


BELMONT, Calif., July 15, 2020 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer in 3D/4D AI medical visualization, is featuring its comprehensive suite of advanced visualization and post-processing applications, on a true vendor neutral platform, at the annual European College of Radiology (ECR) being held virtually from July 15 ? 19, 2020. With over 2,500 installations in 2,000 locations throughout more than 30 countries globally, the company is also highlighting PhyZiodynamicstm in Vivo, which enables virtual dynamic dissection to support precise therapy for organ targeting analyses and Implantations.

"PhyZiodynamics in Vivo offers an unprecedented "real-time" journey through the body non-invasively, supporting diagnoses and treatment planning for a wide variety of organ targets," said Rajeev Taitriya, vice president, Business Development and Marketing for Ziosoft. "Whether for brain, lungs, or other regions of interest, PhyZiodynamics in Vivo, is an advanced 4D processing system, allowing the automated registration of DICOM-based modality images into true fidelity 3D and 4D organ data sets. These data sets then can be interactively interrogated throughout the entire structure while either still or in motion."    

Taitriya also indicated the company will make free Covid-19 advanced visualization software available at no charge. Interested clinicians can visit Ziosoft's virtual ECR booth and request access to this software.

Ziosoft's AI platform provides a robust and clinically validated algorithm, which is driven by both a traditional and new era of machine learning, unlocking the potentials of artificial intelligence (AI) for efficient and repeatable outcomes. The company's flagship Ziostation2 is an economical and scalable multi-departmental solution. A full suite of regulatory cleared 2D, 3D, and 4D analytical tools provides consistent functionality across the enterprise, without compromise. It provides a vendor-neutral advanced visualization platform across multiple imaging modalities. It is also based on architecture that is designed to grow with the future needs of clinicians.

"We use 20 plus years of medical imaging expertise with deep learning to enable accurate segmentation with easy-to-use intuitive tools for efficient and customizable workflows," said Shusuke Chino, co-founder and president, Ziosoft. "This experience has not only brought outstanding 3D/4D to the radiological community, but several other useful tools including 3D printing which can be used in numerous planning endeavors. We look forward to continuing our ongoing developments to expand our AI-enabled visualization platform."

About Ziosoft, Inc.

Ziosoft provides a comprehensive multi-modality, advanced processing and viewing solution for any specialty. Its customizable platform provides automated workflow to maximize efficiency. It is also a scalable, enterprise platform for "anywhere" accessibility and, as a software-only platform, it is simplified to minimize cost of ownership. For further information, visit http://www.ziosoftinc.com.

 

SOURCE Ziosoft


These press releases may also interest you

at 11:35
SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac...

at 11:30
SkyQuest projects that the nanotechnology market will attain a value of USD 53.51 billion by 2031, with a CAGR of 36.4% over the forecast period (2024-2031). The increasing demand for nanotechnology in medical research fuels the demand. During...

at 11:30
The Arnold and Mabel Beckman Foundation announced today the selection of its 2024 class of Arnold O. Beckman Postdoctoral Fellows, individuals who underscore the Foundation's mission of supporting basic research in chemical sciences and chemical...

at 11:02
The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP...

at 11:01
Somavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista Purkyn? University and Masaryk Hospital in Ústí nad Labem in the Czech...

at 11:00
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen...



News published on and distributed by: